NYSE:DTC - Post Discussion
Solo Brands Inc
> Defence Therapeutics Granted CNRI-H from the Canadian Nuclea
Post by
whytestocks on Jul 24, 2024 3:32am
Defence Therapeutics Granted CNRI-H from the Canadian Nuclea
Just In: $DTC Defence Therapeutics Granted CNRI-H from the Canadian Nuclear Laboratories to Accelerate the Development of Its Radio-Immuno-Conjugates ProgramVancouver, British Columbia--(Newsfile Corp. - July 24, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that i...
DTC - Defence Therapeutics Granted CNRI-H from the Canadian Nuclear Laboratories to Accelerate the Development of Its Radio-Immuno-Conjugates Program
Be the first to comment on this post